abstract
- Maurer MS, Kale P, Fontana M, et al; APOLLO-B Trial Investigators. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med. 2023;389:1553-1565. 37888916.
In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- March 2024
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- Amyloid Neuropathies, Familial (MeSH)
- Humans (MeSH)
- Prealbumin (MeSH)
- RNA, Small Interfering (MeSH)
published in
- ACP journal club Journal